
FIFTH CIRCUIT COURT PUTS D.E.A. BACK INSIDE THEIR BOX IN NEUMANN’S PHARMACY VS. DEA
from youarewithinthenorms.com
NORMAN J CLEMENT RPH., DDS, NORMAN L. CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC., SPIRIT OF REV. IN THE SPIRIT OF WALTER R. CLEMENT BS., MS, MBA. HARVEY JENKINS, MD, PH.D., IN THE SPIRIT OF C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., M.B.A., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., EVELYN J. CLEMENT, IN THE SPIRIT OF WALTER F. WRENN III., MD., JULIE KILLINGSWORTH, RENEE BLARE, RPH, DR. TERENCE SASAKI, MD LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, IN THE SPIRIT OF WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., IN THE SPIRIT OF RICHARD KAUL, MD., IN THE SPIRIT OF LEROY BAYLOR, JAY K. JOSHI MD., MBA, AISHA GARDNER, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
DEA’S INVESTIGATIONS UNDER FIRE

Briefing on Allegations of DEA Misconduct in Pharmacy Investigations


This article presents a scathing critique of the Drug Enforcement Administration’s (DEA) enforcement tactics, alleging that agents like Diversion Investigator Richard James Albert intentionally failed to conduct proper investigations, particularly by neglecting to interview prescribing physicians or patients.


The text emphasizes that pharmacies such as Pronto Pharmacy LLC were targeted despite adhering to legal guidelines and implementing robust procedures, including a required “Form” to prevent prescription diversion, which Alpert knowingly dismissed.

The authors argue that the DEA engages in governmental racketeering and abuse of authority by aggressively pursuing health care providers who are “easier enforcement targets” than drug cartels, exemplified by the agency’s aggressive lawsuits against large chains like Walmart and smaller pharmacies like Pronto without sufficient evidence of criminal activity.


The article demands a Congressional investigation into the DEA’s alleged abuses, which it claims are malicious and aimed at shutting down legitimate businesses by ignoring the truth.


RAID ON PRONTO PHARMACY


The investigation into Pronto Pharmacy
The investigation into Pronto Pharmacy is portrayed as a malicious, predetermined effort to shut down the business, marked by a deliberate failure to conduct a thorough and truthful inquiry. Key evidence includes court testimony in which DI Albert admits to not interviewing the prescribing physicians or the patients involved, despite these being central to determining the legitimacy of the prescriptions.

The central argument presented is that the DEA, having lost its “War on Drugs” against armed cartels, now targets legitimate healthcare providers and pharmacies as “easy enforcement targets” to justify its existence and budget.

Furthermore, the DEA allegedly ignored or deliberately misinterpreted proactive compliance measures implemented by the pharmacy, such as a patient screening questionnaire known as “The Form,” which was endorsed by a pharmaceutical expert.


The case is framed within a broader context of federal overreach, citing a similar Department of Justice (DOJ) lawsuit against Walmart. This comparison highlights a pattern of using vague, non-statutory concepts such as “red flags” to scapegoat well-known entities, thereby raising constitutional questions about legal standing. The document concludes with a demand for Congressional oversight of the DEA, the dismissal of the officials involved, and the full reinstatement of Pronto Pharmacy’s license.


The core of the source material is a detailed critique of the DEA’s investigation into Pronto Pharmacy LLC, which the document asserts has never violated any laws and has always dispensed controlled medications in accordance with Controlled Substances Act (CSA) guidelines. The DEA’s actions are described as malicious, targeted, and intended to exact financial hardship to shut the pharmacy down.


A. Failure to Conduct a Thorough Investigation
The primary evidence presented against DI Richard James Alpert is his own testimony under cross-examination, which reveals a lack of fundamental investigative steps. Despite acknowledging his training to be thorough and to run down all available leads, Albert made several key admissions.

Key Admissions from DI Richard James Albert’s Testimony:
| Question Topic | Investigator’s Admission |
| Contacting Prescribing Physicians | When asked by Judge Dowd if it was part of his investigation to reach out to physicians to determine if there was a legitimate medical reason for a prescription, DI Alpert responded, “That wasn’t part of my investigation. No sir.” |
| Interviewing Patients | When asked directly if he spoke to the patients whose prescriptions he found suspicious, DI Alpert stated, “No, sir.” He agreed it could be assumed that speaking with them would have been important. |
| Investigating Prescription Discrepancies | Alpert noted his suspicion was triggered because prescriptions written for tablets were filled as capsules. However, when asked if he talked to the prescribers about authorizing this change, he replied, “No, I did not.” |
| Rationale for Not Investigating | When pressed on why he would not speak to a prescriber to “get to the truth of the matter,” Alpert stated, “Because in my investigation I do not necessarily have to talk to the prescriber based on the investigation that I perform.” |
This testimony is presented as proof of a deliberate “Diversion of The Truth,” where the investigator ignored obvious avenues for collecting evidence that might contradict his predetermined conclusions.

B. Misrepresentation of Pharmacy Compliance Measures: “The Form”
Pronto Pharmacy implemented a required “Memorandum For Record,” referred to as “The Form,” for every patient with any type of prescription.
- Purpose: The Form was used in conjunction with the National Prescription Drug Monitoring Program to screen for suspicious activity, fraudulent prescriptions, and “pharmacy shopping.” It required patients to certify they were taking their medication as prescribed and not selling it.
- Effectiveness: The document claims The Form was “very successful” and that individuals engaged in illicit activities would leave the pharmacy rather than complete it. It led to the imprisonment of some individuals and any suspected fraud was forwarded by the pharmacy’s attorney to law enforcement.
- Expert Endorsement: Pharmacist Daniel Buffington, PharmD, MBA—President-Elect of the Florida Pharmacy Association and a faculty member at the University of Florida—evaluated The Form and agreed with its implementation as part of the pharmacy’s intake procedure. He also supported the pharmacy’s $25 one-time consultation fee associated with the process.
- DEA’s Dismissal: DI Alpert was aware of The Form but allegedly chose not to consider it a component of deterring suspicious activity. Another expert, Donald R. Sullivan, was suspicious of the questionnaire, opining it was insufficient to resolve red flags and was a “subterfuge” by the pharmacy to relieve itself of liability. This testimony is dismissed in the document as “unsubstantiated fraudulent rubbish and bias,” noting that neither Alpert nor Sullivan investigated the origins or legal approval of The Form.


PART -TWO: PRONTO PHARMACY THE FORM MEMORANDUM OF RECORD AND WALMART “RED FLAG”


Systemic Critique of DEA and DOJ Enforcement Strategy
The investigation into Pronto Pharmacy is presented not as an isolated incident but as an example of a broader, flawed, and abusive enforcement strategy by federal agencies.
A. The Walmart Case and “Red Flag” Scrutiny
The document draws a direct parallel between the case against Pronto Pharmacy and a DOJ lawsuit against Walmart. Quoting the Wall Street Journal Editorial Board, it argues that the federal government is “scapegoating a company because it is well-known and has deep pockets.”
- Vague Legal Standards: The lawsuit against Walmart relies heavily on the concept of “red flags.” However, the WSJ is quoted stating that the Controlled Substances Act “does not include the concept of red flags, let alone identify any particular factors as a red flag.” The government’s argument is that failing to resolve red flags violates the “usual course of professional practice,” a standard the source deems contrived.
- Constitutional Issues: The legal strategy raises “constitutional issues based on a lack of legal standing.” The government’s claims are compared to a negligence claim, which is typically a dispute between private parties. The source argues the government can sue for violations of law, but not for vague notions of negligence or failure to adhere to informal “best practices.”
- Federal Overreach: The strategy is characterized as the DOJ asking a federal court “to overrule state law in favor of informal federal guidance.”


B. Alleged Motives for Targeting Healthcare Providers
The document posits several reasons for the DEA’s shift in focus towards prosecuting physicians, pharmacists, and healthcare companies.
- “Easy Enforcement Targets”: The primary claim is that the DEA has lost the “War on Drugs” against heavily armed foreign cartels. In contrast, doctors and pharmacists “don’t return fire with rocket propelled grenades or M-50 machine guns,” making them safer and easier targets for enforcement actions that generate positive headlines.
- Financial Incentives: The DEA is accused of engaging in “extortion and governmental racketeering” against providers and companies (listing Walmart, CVS, Walgreens, and others) to demonstrate its importance to Congress and secure funding. The use of RICO statutes and a DEA-specific court system that “Operates as a Kangaroo Court” are cited as tools in this effort.
- Loss of Marijuana Prosecutions: The decriminalization and legalization of marijuana in many states has allegedly dried up the DEA’s “cash cow.” This has forced the agency to find new targets, leading it to the healthcare sector.

Conclusion and Demands
The source concludes that the investigation of Pronto Pharmacy was baseless and malicious. It asserts there are no facts to support the DEA’s claims that the pharmacy was an “imminent danger” or was illegally manufacturing controlled substances. The actions of DI Alpert and the DEA were intended to ignore the truth and destroy the business.
Based on these findings, the document makes the following demands:
- Reinstatement: The immediate and unrestricted return of the CSA certificate for Pronto Pharmacy LLC.
- Accountability: The removal of Richard James Alpert and Donald Sullivan from their employment with the Federal Government for “fraudulent misrepresentation and abuse of authority.”
- Congressional Oversight: A demand for Congressional hearings and oversight into the DEA’s activities, which are alleged to create healthcare disparities and shortages and are often racially motivated.
🔓 🔓 🔓
ALL WATCHED OVER BY MACHINES OF LOVING GRACE
HUNTED BY DOJ-DEA

BE SURE TO DONATE TO THE MARK IBSEN GOFUNDME DEFENSE FUND, WHERE THE SON ALWAYS RISES!!!

OUR TREE OF KNOWLEDGE SHALL NEVER BE SUPPRESSED




FOR NOW, YOU ARE WITHIN
THE NORMS
REFERENCES:
CRIMINALIZATION OF PAIN CARE

THE ANAND-BOREL-CLEMENT (ABC) PHARMACOLOGICAL TRINITY CONCEPT
ANAND-CLEMENT RULE OF ARTIFICIAL STUPIDITY
https://esmed.org/MRA/mra/article/view/4846
https://cmhrj.com/index.php/cmhrj/article/view/410/246
https://www.scivisionpub.com/…/oversight-on-revision-of…
https://kevinmd.com/…/u-s-opioid-policy-history-how…
https://kevinmd.com/…/the-blind-men-and-the-elephant-a…
https://kevinmd.com/…/modified-dsm-5-opioid-use…
https://kevinmd.com/…/opioid-prescribing-guidelines…
https://esmed.org/MRA/mra/article/view/4726
https://www.frontiersin.org/…/fpain.2021.721357/full
https://www.futuremedicine.com/doi/10.2217/pmt-2021-0112

HUNTED BY DOJ-DEA

Jesse BermanMay 3, 2022
HUNTED BY DOJ-DEA

…richard lawhern ph.d

HUNTED BY DOJ-DEA
